Günter Stalla, MD, PhD

Medicover Neuroendocrinology MVZ
Munich, Germany

Disclosure information not submitted.

Presentation(s):

• SAT-013 - LINC 6 Ad Hoc Analysis of New Osilodrostat Users: Improvements in Quality of Life in Patients with Cushing'S Syndrome

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT

• SAT-013 - LINC 6 Ad Hoc Analysis of New Osilodrostat Users: Improvements in Quality of Life in Patients with Cushing'S Syndrome

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT

• SAT-712 - Setmelanotide Treatment in Patients with Acquired Hypothalamic Obesity and Previous Weight Loss Surgery

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT

• SAT-712 - Setmelanotide Treatment in Patients with Acquired Hypothalamic Obesity and Previous Weight Loss Surgery

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT

• MON-487 - Replacing Early Morning Cortisol Reduces Fatigue in Patients with Adrenal Insufficiency: Post-Hoc Analysis of CHAMPAIN, A Double-Blind Study Comparing Chronocort and Plenadren

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT